On Tuesday, Shares of CBS Corporation (NYSE:CBS) lost -1.24% to $62.69. The share price is trading in a range of $62.33 – 63.65. The stock exchanged hands with 6.02 million shares contrast to its average daily volume of 4.22 million shares.
A former White House executive whose expertise is cybersecurity on the trail of a group of renegades trying to stay off the grid sounds like a Jason Bourne movie — or part of the real-life Congressional hearings on the 2016 presidential election. In this case, it’s neither. Instead, it’s the most recent adventure for Charlotte tech expert Theresa Payton, tapped as the “head of intelligence” as part of a CBS reality TV series debuting this month.
The show, “Hunted,” features nine two-person teams of ordinary citizens trying to elude professional investigators by going on the lam and off the grid. Those runners are up against nine two-person investigative teams made up of U.S. Marshals, Special Ops, FBI, police and military alums.
The investigators in the field work with a high-tech command center that searches for clues through access to the contestants’ cell-phone and online histories and profiles in addition to any current activity. (Participants agreed to grant access to their digital records, but the command center and investigators had to follow law enforcement guidelines in using the information.) All of that cybersnooping and analyzing is where Payton comes in.
She is the former chief information officer at the White House during the George W. Bush administration and runs cybersecurity consulting firm Fortalice Solutions, with offices in Charlotte and Washington. (Fortalice means “fortified house.”) In addition, she is the co-founder of Dark Cubed, a cybersecurity product company. When CBS (NYSE: CBS) began putting the show together, a Fortalice client tapped for industry advice connected producers with Payton and her company. (Source: Charlotte Business Journal)
CBS Corporation (NYSE:CBS) have shown a high EPS growth of 19.40% in the last 5 years and has earnings growth of -50.50% yoy. Analysts have a mean recommendation of 1.90 on this stock (A rating of less than 2 means buy, “hold” within the 3 range, “sell” within the 4 range, and “strong sell” within the 5 range). The stock appeared -6.26% below its 52-week highs and is down -1.62% for the last five trades.
Shares of Mylan NV (NASDAQ:MYL) Showed no change to $38.95. The share price of the stock plunged -32.05% for the year.
Mylan’s CEO said Tuesday that the company has learned from the controversy last year over big price hikes for EpiPen, and that she’s hopeful Donald Trump will appreciate moves the pharmaceutical giant has taken to control the anti-allergy device’s cost to consumers.
The furor over EpiPen “absolutely has made Mylan a stronger company, me a stronger leader,” CEO Heather Bresch told CNBC’s Meg Tirrell during an interview broadcast from the J.P. Morgan Health Care Conference in San Francisco.
“I truly understand the outrage when you have no idea what something’s going to cost,” said Bresch.
She argued that the controversy had focused the issue of hike drug prices though a “patient lens” and created a new “conversation” about what is driving those prices. (Source: CNBC)
Analysts give MYL a mean recommendation of 2.10. The company has dropped -32.05% in past 3 months and in the last five trades has moved down -32.05%. The stock has earnings growth of -127.40% yoy and showed a high EPS growth of 20.20% over the past five years. The stock’s price moved down its 200-day moving average of $40.81. The stock is presently trading up its SMA-50 of $37.28.